Lupin

2019.10

-85.80 (-4.08%) tick

BSE

Buy Sell

NSE BSE

Last updated on 25 Apr 2025 03:33 PM

Open Demat account

Returns

0.68%

Loading chart...

Fundamentals

Large Cap

Financial - Banking

Market Cap (Cr)

96102.38

Earning Per Share

51.04

Dividend Yield

0.49%

P/E Ratio

31.70

P/B Ratio

4.37

Debt to Equity

0.02

Performance

min-value

max-value

Open

56,601.30

52-wk High

75,250.00

High

56,601.30

52-wk Low

75,250.00

Low

56,601.30

Band

75,250.00

Lower Circuit

56,601.30

Upper Circuit

75,250.00

Volume

56,601.30

VWAP

75,250.00

52 Week Performance

min-value

max-value

5.34% down side

up side5.34%

About the company

Lupin is an innovation led Transnational Pharmaceutical Company producing, developing and marketing a wide range of branded & generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally. The Company has significant player in the Cardiovascular, Diabetology, Asthma, Pediatric, Central Nervous System (CNS), Gastro-Intestinal (GI), Anti-Infective and Nonsteroidal Anti Inflammatory Drug (NSAID) therapy segments and is a global leader in the Anti-TB and Cephalosporins segments. Lupin Limited was incorporated in the year 1983 with the name Lupin Chemicals Limited. In March 2001, Lupin Laboratories Limited was amalgamated with the company and the name was changed to Lupin Limited. In the year 1987, the company commenced operations in Cephalexin Plant at Mandideep and 7 ADCA plant at Ankleshwar.

Similar Companies

Sun Pharmaceutical

1781.8 -22.10 (-0.01%) tick

1Yr Returns

+18.66%

Cipla

1525.1 -26.60 (-0.02%) tick

1Yr Returns

+10.34%

Mankind Pharma Limited

2557.5 -41.70 (-0.02%) tick

1Yr Returns

+8.36%

Dr. Reddys Laboratories

1174.8 -25.70 (-0.02%) tick

1Yr Returns

-3.47%

Zydus life

859.65 -20.60 (-0.02%) tick

1Yr Returns

-7.46%